课题基金 / 基金详情

Transcriptional in Chronic Renal Disease Pathogenesis

Transcriptional in Chronic Renal Disease Pathogenesis
慢性肾病发病机制中的转录
批准号:
6712803
负责人:
Leslie A Bruggeman
金额:
$18.94万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2006-01-31

项目摘要

项目成果

Leslie A Bruggeman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of these studies is to identify early and causative events in pathogenic processes common to many chronic renal diseases, such as tubular cyst formation and glomerulosclerosis. We have recently identified the earliest events in pathogenesis, epithelial cell proliferation and apoptosis, in a transgenic mouse model of virus-induced chronic renal disease. These pathogenic events have been shown to occur in many increased transgene expression caused by a persistent activation of NF-kB. NF- kB is known to regulate the expression of numerous genes implicated in renal pathogenesis, and has been proposed to be a common regulatory point in establishing or accelerating disease. Thus, we hypothesize that transgene expression induces a dysregulation of NF-kB, which subsequently activates genes involved in pathogenesis, such as those controlling apoptosis. The specific aims are 1) to examine the mechanism of dysregulated NF-kB activation and its effect on gene expression in renal cells, and 2) investigate the mechanism(s) of apoptosis and the role of NF-kB in mediating apoptosis. To accomplish these studies, we have developed an in vitro system that will allow us to functionally test the regulatory role of NF-kB in mediating epithelial cell dysfunction. We will define the composition of NF-kB complexes in glomerular and tubular epithelial cells by electrophoretic mobility shift assays and western blotting. The mechanism of persistent NF-kB activation will be determined using specific inhibitors of NF-kB and dominant mutants of the critical regulatory proteins, IkBalpha and IkBbeta. The mechanism of apoptosis will be determined as well as the regulatory role of NF-kB. Thus, the long-term goal of this proposal is to better understand at the molecular level the initiating events that occur in chronic renal disease pathogenesis. An understanding of how these initiating pathogenic events are regulated may lead to the design of more effective interventional strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Kidney Diseases Associated With APOL1 Variation
  • 批准号:
    10607630
  • 项目类别:
  • 资助金额:
    $70.13万
  • 财政年份:
    2023
  • 负责人:
    Leslie A Bruggeman
  • 依托单位:
Intracellular functions of APOL1 in the kidney
  • 批准号:
    10383979
  • 项目类别:
  • 资助金额:
    $56.49万
  • 财政年份:
    2021
  • 负责人:
    Leslie A Bruggeman
  • 依托单位:
Intracellular functions of APOL1 in the kidney
  • 批准号:
    10493392
  • 项目类别:
  • 资助金额:
    $56.49万
  • 财政年份:
    2021
  • 负责人:
    Leslie A Bruggeman
  • 依托单位:
Intracellular functions of APOL1 in the kidney
  • 批准号:
    10666584
  • 项目类别:
  • 资助金额:
    $56.49万
  • 财政年份:
    2021
  • 负责人:
    Leslie A Bruggeman
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: